Long-term diabetes outcomes after bariatric surgery-managing medication withdrawl.

Pedro SouteiroSandra BeloDaniela MagalhãesJorge PedroJoão Sérgio NevesSofia Castro OliveiraPaula FreitasAna VarelaDavide Carvalhonull null

Published in: International journal of obesity (2005) (2019)

Baseline HbA1c and EBWL were the main variables driving both T2DM relapse after bariatric surgery and the attempt to withdrawal anti-diabetic medication. In our population keeping metformin once an HbA1c < 6.0% is achieved did not seem to diminish relapse but further studies on this matter are needed.

Keyphrases

type diabetes
glycemic control
free survival
adverse drug
healthcare
cardiovascular disease
wound healing
emergency department
skeletal muscle
metabolic syndrome
insulin resistance
weight loss